(Q52010541)

English

Treatment with haloperidol or clozapine causes changes in dopamine receptors but not adenylate cyclase or protein kinase C in the rat forebrain.

scientific article published in January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

Treatment with haloperidol or clozapine causes changes in dopamine receptors but not adenylate cyclase or protein kinase C in the rat forebrain. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

author name string

Wan DC

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

Pavey G

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

Copolov DL

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

language of work or name

0 references

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

59

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

23

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

2001-2008

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Dopamine and the Pathophysiology of Dyskinesias Induced by Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Effects of chronic treatment of haloperidol and clozapine on levels of G-protein subunits in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Quantitative autoradiography of [3H]forskolin binding sites in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Nigral dopamine type-1 receptors are reduced in Huntington's disease: a postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Increased forskolin binding in the left parahippocampal gyrus and CA1 region in post mortem schizophrenic brain determined by quantitative autoradiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

New insights into the biology of schizophrenia through the mechanism of action of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Drug strategies and treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900551-6

7 January 2021

Identifiers

10.1016/S0024-3205(96)00551-6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/8950299

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52010541&oldid=1531391082"